Shilajit/Fulvic Acid / Twist Cancer Research Results

FulvicA, Shilajit/Fulvic Acid: Click to Expand ⟱
Features:
Fulvic acid is a naturally occurring compound found in soil, compost, and marine sediments. It is a complex mixture of many organic acids and has been studied for its antioxidant, anti-inflammatory, and immune-modulating properties.
Shilajit is a complex mineral–organic exudate found in mountainous regions (e.g., Himalayas). It contains fulvic acids, humic substances, dibenzo-α-pyrones (DBPs), trace minerals, and other low-molecular-weight compounds. Most standardized extracts are characterized by fulvic acid content (often 15–60%).

AD:
-Fulvic acid may help inhibit tau fibril formatio
-Antioxidant activity
-Anti-inflammatory effects

Cancer:
-Fulvic acid’s role in reducing drug resistance and improving drug absorption has been suggested
-Synergistic effects with chemotherapy

Fulvic Acid database results: Note how it is antioxidant for normal cells, but may produce ROS in cancer cells. (explains synergistic effect with chemo)
LeafSource Fulvic Acid note how they use Fulvic Acid to improve bioavailability of berberine.

Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 Mitochondrial function / electron transport support Bioenergetic modulation (context-dependent) ATP production support ↑ (reported) P, R Mitochondrial optimization Dibenzo-α-pyrones and fulvic acids are reported to support mitochondrial respiration in non-cancer models.
2 Nrf2 / antioxidant response Redox tone modulation (model-dependent) Nrf2 ↑; antioxidant enzymes ↑ R, G Redox buffering Commonly described as antioxidant; tumor-direction effects are not well established.
3 NF-κB inflammatory signaling NF-κB ↓ (reported; limited cancer data) Inflammation tone ↓ R, G Anti-inflammatory modulation Anti-inflammatory effects are better documented than direct tumor cytotoxicity.
4 ROS modulation ROS ↓ or stabilized (context-dependent) Oxidative stress ↓ P, R, G Antioxidant effect Acts primarily as redox stabilizer rather than ROS generator.
5 AMPK / metabolic stress pathways Metabolic modulation (limited direct tumor evidence) Energy homeostasis support ↑ R, G Metabolic adaptation Some reports suggest improved metabolic efficiency; not a primary oncologic mechanism.
6 Cell-cycle / apoptosis Apoptosis ↑ (reported in limited preclinical studies) ↔ G Conditional cytotoxicity Data are sparse and largely cell-line based; not a strong, consistent cytotoxic signature.
7 Immune modulation Immune tone modulation (context-dependent) Immune support ↑ R, G Adaptogenic effect Traditional use emphasizes immune and vitality support rather than direct anticancer activity.
8 Metal chelation / mineral transport Trace mineral transport effects (uncertain tumor relevance) Mineral absorption modulation P Biochemical modulation Fulvic acid has chelation properties; relevance to oncology unclear.
9 Quality / contamination risk Variable depending on preparation Heavy metal exposure risk if unrefined — Safety constraint Crude shilajit may contain heavy metals; purified standardized extracts preferred.
10 Bioavailability variability Systemic exposure varies by extraction/purification — — Translation constraint Composition varies widely; standardization typically based on fulvic acid content.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (rapid mitochondrial/redox interactions)
  • R: 30 min–3 hr (acute signaling and metabolic shifts)
  • G: >3 hr (gene-regulatory adaptation and phenotype outcomes)
Twist, Twist: Click to Expand ⟱
Source:
Type: transcription factor
Twist, the basic helix-loop-helix transcription factor, is involved in the process of epithelial to mesenchymal transitions (EMTs), which play an essential role in cancer metastasis. Overexpression of Twist or its promoter methylation is a common scenario in metastatic carcinomas. Twist is a key transcription factor for Epithelial-mesenchymal transition (EMT).
Twist-1 overexpression was shown, recently, to be a factor of poor prognosis in melanomas Many studies use “TWIST” and “TWIST1” interchangeably (with TWIST1 being the canonical factor in humans.

Twist plays key roles in embryonic development and has been implicated in cancer progression, particularly through promoting epithelial-mesenchymal transition (EMT), invasion, and metastasis. TWIST1 directly represses epithelial markers (e.g., E-cadherin) while upregulating mesenchymal markers (e.g., N-cadherin, vimentin).

Twist is most often upregulated in cancer cells compared to normal cells across multiple tumor types.
– High Twist expression is consistently associated with aggressive clinical features, including increased invasiveness, metastasis, and reduced overall survival.
Scientific Papers found: Click to Expand⟱
4027- FulvicA,    Mummy Induces Apoptosis Through Inhibiting of Epithelial-Mesenchymal Transition (EMT) in Human Breast Cancer Cells
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF-7 - in-vitro, Nor, MCF10
tumCV↓, selectivity↑, TGF-β↓, Twist↓, NOTCH1↓, CTNNB1↓, Src↓, E-cadherin↑, EMT↓, TumMeta↓, BioAv↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Transcription & Epigenetics ⓘ

tumCV↓, 1,  

Proliferation, Differentiation & Cell State ⓘ

CTNNB1↓, 1,   EMT↓, 1,   NOTCH1↓, 1,   Src↓, 1,  

Migration ⓘ

E-cadherin↑, 1,   TGF-β↓, 1,   TumMeta↓, 1,   Twist↓, 1,  

Drug Metabolism & Resistance ⓘ

BioAv↑, 1,   selectivity↑, 1,  
Total Targets: 11

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: Twist, Twist
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:358  Target#:421  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page